Medindia LOGIN REGISTER
Medindia

Side effect(s) of Ibalizumab-uiyk


Review the side-effects of Ibalizumab-uiyk as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the instances these side-effects are mild and easily tolerable, however sometimes they can be more severe and can be detrimental.

If the side effects are not tolerable adjusting the dosage or switching to a different medication can help to manage or overcome side effects. If you have any doubts or questions, we recommend seeking advice from your doctor or pharmacist.
• Nausea
Diarrhea
• Dizziness
Rashes (erythematous, maculopapular or generalized)
• Changes in the immune system

Other Precautions :

• The infusion schedule should be followed strictly and should not be changed or stopped without the physician’s advice.
• If a maintenance dose of 800 mg ibalizumab-uiyk is missed for more than three days, a loading dose of 2000 mg should be given as soon as possible followed by a maintenance dose of 800 mg for every two weeks.
• Ibalizumab-uiyk vials should be inspected for the presence of any particulate matter or discoloration. Discard the vials immediately if any of those are found.

Drug Name : Ibalizumab-uiyk

Ibalizumab-uiyk generic Ibalizumab-uiyk intravenous injection is prescribed along with other antiretroviral medications to treat human immunodeficiency virus-1 (HIV-1) infection in adults.It is used for HIV patients with- • Previous history of antiretroviral therapies • Multidrug-resistant HIV-1 infection • Failure or loss of response with other antiretroviral medicines Ibalizumab-uiyk is a post attachment inhibitor that binds to CD4 glycoprotein, the primary receptor for human immunodeficiency virus and blocks the viral entry process into the immune cells.


Advertisement